FDA Warns Users of Critical Alerts Risks with Smartphone Diabetes Devices

The FDA has issued a warning to diabetes patients regarding the risk of missing critical alerts from smartphone-connected medical devices, such as continuous glucose monitors and insulin pumps. Reports indicate that improper smartphone settings, particularly following software or hardware updates, can lead to dangerous situations like severe hypoglycemia or hyperglycemia. Users are advised to disable automatic operating system updates, verify alert settings after connecting new accessories, and regularly check notification configurations to ensure alerts are functioning properly. The agency emphasizes that even small changes, like connecting to wireless earphones, can affect alert delivery. Given the significant number of Americans living with diabetes, ensuring these devices work as intended is crucial for patient safety. The FDA is working with manufacturers to address these issues and improve device reliability.